In the news:
GSK hails progress for withdrawn blood cancer drug - GSK lowers vaccine sales forecast as weak demand for RSV jab Arexvy takes toll - UK firm GSK to pay $2.2bn over Zantac cancer claims - GSK shares jump after drugmaker reaches $2.2bn Zantac settlement - GSK strikes $2.2bn deal to resolve legal cases in US over heartburn treatment Zantac - GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits - GSK's problem is it has more than one source of pain - GSK's ex-vaccines chief says its jab for a flu-like virus is too expensive - HUL gets Rs 1k crore notice over TDS dispute in GSK deal - GSK Lifts Outlook as Earnings Rise
GSK
Save
ShareKey facts
- country: United Kingdom
- sector: Health Care
- industry: Pharmaceuticals
Classified as: organization
Summary
GSK is a company. It is located in the United Kingdom. The company is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Business
GSK is one of the companies in the United Kingdom, companies in Pharmaceuticals, companies in Health Care and 3,466,499 companies in our database.
Stocks from GSK
Explore more on business
Talking Points:
- GSK Careers Apply
- GSK Careers Apply
- We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://t.co/NdSNH7YhFc
- A science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. | A science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and ...
Learn more about talking points